Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)

NCT01783548 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

547

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis

Interventions

DRUG: BDP Nasal Aerosol
DRUG: Placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.